PICS vs CRVS
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
PICS · PicS NV$6.86 ▼ 3.24%
CRVS · Corvus Pharmaceuticals$10.54 ▲ 8.32%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- PICS -63.9%
- CRVS -49.7%
Head to head
| Metric | PICS | CRVS |
|---|---|---|
| Price | $6.86 | $10.54 |
| Change today | ▼ 3.24% | ▲ 8.32% |
| Market cap | $888.97M | $889.08M |
| Return, 3 months | -40.5% | -23.3% |
| Return, year to date | – | +36.9% |
| Return, 1 year | – | +38.7% |
| P/E (TTM) | 3.7 | – |
| P/B | 0.8 | 4.3 |
| P/E percentile vs own 5y | 8th | 18th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +62.1% | – |
| Net profit growth (YoY) | +123.7% | -124.5% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 16.0% | – |
| Return on equity | 30.2% | -35.4% |
| Analyst target vs. price | +186.7% | +172.8% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 31 | 50 |
| 30-day volatility | 172.4% | 61.8% |
| Max drawdown, 1 year | -64.8% | -63.2% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CRVS is the largest of the group by market value.
- CRVS has been the calmest stock over the last 30 days.